3-Hydroxybutyric acid (3-HBA), also known as beta-hydroxybutyrate, is a key ketone body essential for energy metabolism during low glucose availability.
Produced in the liver from acetyl-CoA, 3-HBA provides an alternative energy source for the brain during fasting, starvation, or ketogenic diets. Elevated levels of 3-HBA indicate ketosis, which is common in diabetic ketoacidosis and certain metabolic disorders.
This ketone body is crucial for energy supply to the brain and lungs in developing mammals and plays a significant role in lipid synthesis.
Recent studies highlight the potential of 3-HBA as a biomarker for prenatal screening of Down syndrome and various metabolic conditions.
Laboratory tests for 3-HBA in blood and urine help monitor ketosis and assess metabolic health. Optimal 3-HBA levels vary based on individual medical history, with elevated levels potentially indicating metabolic disorders or diabetic ketoacidosis.
Comprehensive assessment alongside related biomarkers such as acetoacetate, acetone, glucose, and insulin is essential for accurate diagnosis and management.
3-Hydroxybutyric acid, also known as beta-hydroxybutyrate, is a ketone body used for energy metabolism, especially during low glucose conditions. Synthesized in the liver from acetyl-CoA, it is an energy source for the brain during periods of low blood sugar.
It is one of the three main ketone bodies produced during ketosis, along with acetoacetate and acetone. Ketosis occurs when the body burns fat for energy instead of carbohydrates, such as during fasting, starvation, or following a ketogenic diet.
Despite being a potentially toxic compound, it is also utilized in synthesizing biodegradable plastics.
3-hydroxybutyric acid is one of the three main ketone bodies produced during ketosis, along with acetoacetate and acetone.
Elevated levels of 3-hydroxybutyrate in blood and urine indicate ketosis, common in diabetic ketoacidosis and newborns with persistent mild hyperketonemia.
Ketone bodies including 3-hydroxybutyrate are vital for providing energy to extrahepatic tissues such as the brain and lungs in developing mammals. They are preferred over glucose for synthesizing crucial lipids during early development, aiding in brain growth, myelination, and lung function.
Additionally, 3-hydroxybutyric acid plays a role in the synthesis of cholesterol, fatty acids, and complex lipids.
3-Hydroxybutyric acid can cross the blood-brain barrier and has been found to act as a histone deacetylase (HDAC) inhibitor, potentially influencing brain-derived neurotrophic factor (BDNF) levels and TrkB signaling in the hippocampus.
Elevated levels of 3-HBA can serve as a biomarker for various metabolic disorders, including diabetic ketoacidosis, starvation ketosis, and inborn errors of metabolism like fumarase deficiency and medium-chain acyl-CoA dehydrogenase deficiency.
Down syndrome, a genetic disorder caused by an extra chromosome 21, can be screened and diagnosed using metabolomics to identify new biomarkers.
In a recent study, 3-hydroxybutyric acid was analyzed as a potential marker for prenatal diagnosis of Down syndrome. Using LC-MS/MS, researchers quantified 3-hydroxybutyric acid in plasma samples from pregnant women. [10.]
In plasma samples, a significant increase in 3-hydroxybutyric acid levels was observed in the Down syndrome group compared to the healthy group (p < 0.01). This finding supports the use of 3-hydroxybutyric acid as a valuable biomarker for prenatal screening and diagnosis of Down syndrome.
Blood and urine samples are commonly used for 3-HBA analysis. Urine testing is commonly used for the analysis of ketone bodies, particularly for monitoring ketoacidosis in individuals with diabetes or other conditions that increase the risk of ketone accumulation. [5., 10.]
Fasting or non-fasting state may affect 3-HBA levels, and this information should be considered when interpreting test results.
Levels of 3-hydroxybutyric acid should be interpreted within the clinical context of an individual’s medical history. Some individuals may wish to maintain relatively high levels of 3-hydroxybutyric acid, for example while following a ketogenic diet.
In the absence of this, high levels of 3-hydroxybutyric acid should be assessed for inborn errors of metabolism or diabetic ketoacidosis.
One laboratory represents an optimal level of 3-hydroxybutyric acid as: < 60.5
nmol/mg Creatinine [8.]
3-HBA levels are typically low, but they can increase significantly in certain conditions, such as diabetic ketoacidosis, starvation ketosis, and inborn errors of metabolism.
Elevated 3-HBA levels may also be observed in other situations, such as during radiotherapy treatment for cancer. [7.]
Interpreting 3-HBA test results requires consideration of the clinical context and the presence of other related biomarkers.
Low levels of 3-hydroxybutyric acid are not considered clinically significant.
Acetoacetate and acetone are the two other primary ketone bodies produced by the liver during periods of low carbohydrate availability. As they are in equilibrium with 3-HBA, all are elevated in conditions such as diabetic ketoacidosis and starvation ketosis.
Lab testing for acetoacetate and acetone can be performed using similar analytical methods as those used for 3-HBA.
Glucose is a crucial biomarker in the context of ketosis and diabetic ketoacidosis.
Hyperglycemia, or elevated blood glucose levels, is a hallmark of diabetic ketoacidosis and is often measured alongside ketone bodies to assess the severity of the condition.
Insulin is a hormone that plays a key role in regulating ketone body production5. Low insulin levels or insulin resistance can lead to increased ketogenesis and elevated 3-HBA levels.
While insulin is not directly measured as a biomarker for 3-HBA-related conditions, it is an important factor to consider in the overall clinical context.
Click here to compare testing options and order tests for 3-Hydroxybutyric Acid levels.
[1.] 3-hydroxybutyric acid — TargetMol Chemicals. www.targetmol.com. Accessed May 30, 2024. https://www.targetmol.com/compound/3-Hydroxybutyric%20acid
[2.] 3-Hydroxybutyric acid (YMDB01561) - Yeast Metabolome Database. www.ymdb.ca. Accessed May 30, 2024. https://www.ymdb.ca/compounds/YMDB01561
[3.] 3-hydroxybutyric acid (CHEBI:20067). www.ebi.ac.uk. Accessed May 30, 2024. https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:20067
[4.] Cantrell CB, Mohiuddin SS. Biochemistry, Ketone Metabolism. [Updated 2023 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554523/
[5.] Penders J, Fiers T, Giri M, Wuyts B, Ysewyn L, Delanghe JR. Quantitative measurement of ketone bodies in urine using reflectometry. Clin Chem Lab Med. 2005;43(7):724-9. doi: 10.1515/CCLM.2005.123. PMID: 16207132.
[6.] PubChem. 3-Hydroxybutyric acid. pubchem.ncbi.nlm.nih.gov. https://pubchem.ncbi.nlm.nih.gov/compound/3-Hydroxybutyric-acid
[7.] Roś-Mazurczyk M, Wojakowska A, Marczak Ł, Polański K, Pietrowska M, Jelonek K, Domińczyk I, Hajduk A, Rutkowski T, Składowski K, Widłak P. Ionizing radiation affects profile of serum metabolites: increased level of 3-hydroxybutyric acid in serum of cancer patients treated with radiotherapy. Acta Biochim Pol. 2017;64(1):189-193. doi: 10.18388/abp.2016_1301. Epub 2016 Nov 4. PMID: 27815965.
[8.] Rupa Health. OMX - Urine + Plasma Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1NWreSzJjfxdBXEi_D2ZjqEaEO1K_GeM2/view
[9.] Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate. Elife. 2016 Jun 2;5:e15092. doi: 10.7554/eLife.15092. PMID: 27253067; PMCID: PMC4915811.
[10.] Tuba REÇBER, Ece ÖZKAN, Emirhan NEMUTLU, Mehmet Sinan BEKSAC, Sedef KIR. Analysis of 3-hydroxyisovaleric acid and 3-hydroxybutyric acid in plasma samples by LC-MS/MS. Journal of research in pharmacy. 2022;26(1)(26(1)):1153-1161. doi:https://doi.org/10.29228/jrp.110
[11.] Voulgari C, Tentolouris N. The performance of a glucose-ketone meter in the diagnosis of diabetic ketoacidosis in patients with type 2 diabetes in the emergency room. Diabetes Technol Ther. 2010 Jul;12(7):529-35. doi: 10.1089/dia.2010.0011. PMID: 20597827.